Early detection of oxygen levels is crucial for preventing organ failure and saving lives. The Opticyte VitalO₂ is the first device to monitor both cellular oxygen and blood oxygen saturation (pulse oximetry) in real time. By combining these technologies, VitalO₂ provides comprehensive data to diagnose, treat, and track patient responses. Our commitment to health equity ensures that every patient, regardless of skin tone, receives accurate and timely care through advanced monitoring.
Introducing the
Opticyte VitalO₂
Delivering Definitive Data
When it Matters Most
Advanced Detection of Oxygen Deficiency for Equitable Patient Care
The Opticyte VitalO₂ empowers clinicians with the ability to detect oxygen deficiency both in blood and in organs quickly for earlier intervention. With continuous monitoring, patients will receive personalized precision medicine. This breakthrough, noninvasive technology provides clinicians with an unprecedented, complete picture of a patient’s oxygen levels, from the heart to organ cells, in real time. By allowing them to more quickly narrow in on the source of the health issue and determine precisely when a patient’s oxygen levels are restored, clinicians can make informed, timely decisions that can significantly improve patient outcomes.
Shining Light on the Next Standard of Care
Opticyte’s VitalO₂
One device, Two Essential O₂ Measurements Unbiased by Skin Color
Pulse Ox Technology is Inadequate
Two Critical Healthcare Crises. One Proprietary Solution
Issue #1: Sepsis can quickly result in organ failure and death if not recognized early, yet patients with sepsis have vague symptoms that commonly overlap with other conditions, making it difficult to catch in time with today’s standard of care.
Issue #2: Traditional pulse oximeters are used on every hospital patient and make errors in patients with darker skin tones that result in more organ failure and death than in patients with lighter skin.
The Opticyte VitalO₂ provides the industry’s first solution to address both of these critical issues.
VitalO₂ delivers the first noninvasive cellular oxygenation measurement. Together with pulse oximetry, VitalO₂ provides two real-time metrics that give clinicians a full picture of a patient’s oxygen status, from the heart to organ cells, where oxygen fuels the body’s vital functions. This comprehensive data enables quicker, more informed interventions across a range of conditions, including sepsis, trauma, and respiratory illnesses like pneumonia, and COVID, allowing clinicians to not only identify systemic oxygenation issues but also have insight into their source.
Zoom to Cell Level
A Beacon to Prevent Organ Failure
VitalO₂ is the World’s First Device to Measure Oxygen in Cells
The Opticyte VitalO₂ shines light in the visible and near-infrared spectrum (500-800 nm) through the skin on the patient’s palm and measures the reflected light. Opticyte’s proprietary pattern-matching algorithm analyzes the optical spectra to produce real-time cellular oxygenation measurements from the patient’s muscle tissue. When there is systemic oxygen deficiency, cells in muscle and core organs like the brain, heart, lungs, kidneys, and liver are deprived of oxygen. Therefore, low oxygen levels in muscle are correlated with low oxygen levels in critical organs and eventual organ failure.
Published Peer-Reviewed Research and Papers
Learn more about Opticyte’s VitalO₂ technology in these published case studies.